NDC 0591-5726-01 - Hydroxyzine Pamoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-5726
- Requested NDC
- 0591-5726-01
- Package NDCs from labels
- 0591-5726-01, 0591-5726-05
- Manufacturer
- Watson Labs
- Effective date
- 2007-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydroxyzine Pamoate - Watson Labs | Watson Labs | 2007-01-01 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-5726-01 | Hydroxyzine Pamoate | 100 in 1 BOTTLE | CAPSULE | 100 | 1 | |
| 0591-5726-05 | Hydroxyzine Pamoate | 500 in 1 BOTTLE | CAPSULE | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | Bryant Ranch Prepack | f24c19d4-fd3e-4ed3-aeb7-7bc5e0dd0244 | 2023-08-10 | Warnings, Adverse reactions | 995253 |
| hydroxyzine pamoate | HYDROXYZINE PAMOATE | Proficient Rx LP | b7f806ed-da18-41f2-aa0b-bce2336f2756 | 2022-11-01 | Warnings, Adverse reactions | 995253 |
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | Proficient Rx LP | 04657694-e8a8-4e52-a179-cfe752819760 | 2022-11-01 | Warnings, Adverse reactions | 995253 |
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | Proficient Rx LP | 23561142-45e0-46f5-b17f-d67760b4db27 | 2022-11-01 | Warnings, Adverse reactions | 995253 |
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | Teva Pharmaceuticals USA, Inc. | 06068fff-2e79-4721-bcc7-b0938aa20e7a | 2022-10-01 | Warnings, Adverse reactions | 995253 |
| hydroxyzine pamoate | HYDROXYZINE PAMOATE | Sandoz Inc | c38cfd32-2562-4d6c-8a2e-d9984c16d9eb | 2022-06-27 | Warnings, Adverse reactions | 995253 |
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | Proficient Rx LP | b098e287-e489-4cdc-9171-7daf50380c1c | 2022-06-01 | Warnings, Adverse reactions | 995253 |
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | NCS HealthCare of KY, LLC dba Vangard Labs | 207d3478-ac7f-485c-b8ca-e9fcebbdcd89 | 2022-02-10 | Warnings, Adverse reactions | 995253 |
| Hydroxyzine Pamoate | HYDROXYZINE PAMOATE | Aphena Pharma Solutions - Tennessee, LLC | d6a1df2e-c111-4ee7-9d56-469db19b7c60 | 2021-10-15 | Warnings, Adverse reactions | 995253 |
| hydroxyzine pamoate | HYDROXYZINE PAMOATE | Proficient Rx LP | bff75226-d194-4d64-bcbb-d7d79f5d230e | 2021-05-01 | Warnings, Adverse reactions | 995253 |
| A6EDD742-30B1-4427-BCA8-A81F7EBB2BC6 | A6EDD742-30B1-4427-BCA8-A81F7EBB2BC6 | 2007-01-01 | Adverse reactions | A6EDD742-30B1-4427-BCA8-A81F7EBB2BC6 A6EDD742-30B1-4427-BCA8-A81F7EBB2BC6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.